Bio-Rad Laboratories, Inc. Class B

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO.B and other ETFs, options, and stocks.

About BIO.B

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,700
Employees7,700
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,700
Employees7,700

BIO.B Key Statistics

Market cap
7.96B
Market cap7.96B
Price-Earnings ratio
-12.14
Price-Earnings ratio-12.14
Dividend yield
Dividend yield
Average volume
196.40
Average volume196.40
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$343.85
52 Week high$343.85
52 Week low
$225.29
52 Week low$225.29

Stock Snapshot

The current Bio-Rad Laboratories, Inc. Class B(BIO.B) stock price is $295.05, with a market capitalization of 7.96B. The stock trades at a price-to-earnings (P/E) ratio of -12.14.

On 2026-02-11, Bio-Rad Laboratories, Inc. Class B(BIO.B) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Bio-Rad Laboratories, Inc. Class B(BIO.B) stock has reached 0, versus its average volume of 196.4.

Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class B(BIO.B) stock has traded between a high of $343.85 and a low of $225.29.

Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class B(BIO.B) stock has traded between a high of $343.85 and a low of $225.29.

BIO.B News

Simply Wall St 1d
Is AOAC Validation Of EZ-Check Listeria Kits Altering The Investment Case For Bio-Rad Laboratories?

Bio-Rad Laboratories recently received AOAC International validation for its EZ-Check Listeria spp. Kit and EZ-Check Listeria monocytogenes Kit, which are desig...

Is AOAC Validation Of EZ-Check Listeria Kits Altering The Investment Case For Bio-Rad Laboratories?

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

People also own

Based on the portfolios of people who own BIO.B. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.